Your shopping cart is currently empty

SMU-V18 is a vesicular stomatitis virus (VSV) inhibitor with an EC50 of 6.2 μM. It suppresses VSV-GFP fluorescence intensity, viral mRNA/protein expression, and progeny virus replication. SMU-V18 interferes with the early stages of viral infection and is effective against wild-type VSV (VSV-WT). Additionally, it suppresses VSV-GFP in mouse tissues and extends survival in mice. SMU-V18 is useful for studying vesicular stomatitis virus (VSV) infections.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | SMU-V18 is a vesicular stomatitis virus (VSV) inhibitor with an EC50 of 6.2 μM. It suppresses VSV-GFP fluorescence intensity, viral mRNA/protein expression, and progeny virus replication. SMU-V18 interferes with the early stages of viral infection and is effective against wild-type VSV (VSV-WT). Additionally, it suppresses VSV-GFP in mouse tissues and extends survival in mice. SMU-V18 is useful for studying vesicular stomatitis virus (VSV) infections. |
| In vitro | SMU-V18 significantly inhibits VSV-GFP replication in HeLa cells at concentrations of 1.2-40 μM over 24 hours, with an EC50 of 6.2 μM, reducing GFP fluorescence intensity, VSV-P mRNA, and GFP expression. It also effectively suppresses the release of progeny VSV-GFP at 5-20 μM during 24-hour incubation. In Vero cells, SMU-V18 at 5-20 μM over 6-24 hours markedly inhibits VSV-WT replication, decreases VSV-WT plaque formation, and lowers viral mRNA levels across different MOI and incubation durations. Real Time qPCR analysis shows reduced VSV-P mRNA levels after treatment. |
| In vivo | SMU-V18 (25-50 mg/kg, intraperitoneal injection, once daily for 5 days) significantly reduces VSV-GFP replication in mouse tissues. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.